PeptideDB

Shizukaol B

CAS No.: 142279-40-1

Shizukaol B exerts anti-inflammatory effects in LPS-activated microglia partly by modulating JNK-AP-1 signaling pathway;
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Shizukaol B exerts anti-inflammatory effects in LPS-activated microglia partly by modulating JNK-AP-1 signaling pathway; it also shows significant anti-neuroinflammatory effects by inhibiting nitric-oxide (NO) production in lipopolysaccharide (LPS)-stimulated murine BV-2 microglial cells with relatively low cytotoxicity. Shizukaol B exhibits anti-HIV-1 replication activities in both wild-type HIV-1 and two NNRTIs-resistant strains, it also has significant cytotoxicities against C8166 cells. Shizukaol B prevents monocyte adhesion to HUVEC through the inhibition of cell adhesion molecules expression stimulated by TNF-alpha.
molecular weight 732.77
Molecular formula C40H44O13
CAS 142279-40-1
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year